Risk factors, clinical features and outcome of Acinetobacter bacteremia in adults

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 16, Issue 10, 1997, Pages 737-740

  Poutanen, S M ^a   Louie, M ^a   Simor, A E ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACINETOBACTER; AGE; AGED; ARTICLE; BACTEREMIA; BLOOD CLOTTING DISORDER; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE; MALE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SEPTIC SHOCK; TREATMENT OUTCOME;

ACINETOBACTER; ACINETOBACTER INFECTIONS; ADULT; AGE FACTORS; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; BLOOD COAGULATION DISORDERS; CROSS INFECTION; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SHOCK, SEPTIC;

EID: 0030669033     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01709254     Document Type: Article

References (13)

1. Bergogne-Bérézin E, Towner KJ: Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clinical Microbiology Reviews 1996, 9: 148-165.
2. Retailliau HF, Hightower AW, Dixon RE, Allen JR: Acinetobacter calcoaceticus: a nosocomial pathogen with an unusual seasonal pattern. Journal of Infectious Diseases 1979, 139: 371-375.
3. Smego RA: Endemic nosocomial Acinetobacter calcoaceticus bacteremia: clinical significance, treatment, and prognosis. Archives of Internal Medicine 1985, 145: 2174-2179.
4. Tilley PAG, Roberts FJ: Bacteremia with Acinetobacter species: risk factors and prognosis in different clinical settings. Clinical Infectious Diseases 1992, 18: 896-900.
5. Seifert H, Strate A, Pulverer G: Nosocomial bacteremia due to Acinetobacter baumannii: clinical features, epidemiology, and predictors of mortality. Medicine 1995, 74: 340-349.
6. Cisneros JM, Reyes MJ, Pachón J, Becerril B, Caballero FJ, Garcia-Garmendia JL, Ortiz C, Cobacho AR: Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features. Clinical Infectious Diseases 1996, 22: 1026-1032.
7. von Graevenitz A: Acinetobacter, Alcaligenes, Moraxella, and other nonfermentative gram-negative bacteria. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RD (ed): Manual of Clinical Microbiology, Washington, DC, 1995, p. 520-532.
8. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4. NCCLS, Wayne, PA, 1997.
9. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM: CDC definitions for nosocomial infections, 1988. American Journal of Infection Control 1988, 16: 128-140.
10. McCabe WR, Jackson GG: Gram-negative bacteremia: etiology and ecology. Archives of Internal Medicine 1962, 110: 847-855.
11. Crombach WHJ, Dijkshoorn L, van Noort-Klaassen M, Niessen J, van Knippenberg-Gordebeke G: Control of an epidemic spread of a multi-resistant strain of Acinetobacter calcoaceticus in a hospital. Intensive Care Medicine 1989, 15: 166-170.
12. Timsit J-F, Garrait V, Misset B, Goldstein FW, Renaud B, Carlet J: The digestive tract is a major site for Acinetobacter baumannii colonization in intensive care unit patients. Journal of Infectious Diseases 1993, 168: 1336-1337.
13. Seifert H, Strate A, Schulze A, Pulverer G: Bacteremia due to Acinetobacter species other than Acinetobacter baumannii. Infection 1994, 22: 379-385.